Evidence map›Paper›PMID 24244785›Full record

ReviewEplasty2013

Split rejection in vascularized composite allotransplantation.

Indranil Sinha, Bohdan Pomahac

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Eplasty, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01281267 (Transplantation of Allograft Face or Facial Subunit for Treatment of Severe Facial Deformation), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01281267 nacompletednot on this map

Transplantation of Allograft Face or Facial Subunit for Treatment of Severe Facial Deformation

TypeinterventionalSponsorBrigham and Women's HospitalRan2009 to 2019Enrolled10ConditionsSevere Facial DeformityArmsFacial Allograft Transplantation
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.Transplant international : official journal of the European Society for Organ Transplantation · 2016
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Indranil SinhaDivision of Plastic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, Mass.
Bohdan Pomahac
Brigham and Women's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGraft monitoring following vascularized composite allotransplantation (VCA) relies primarily on serial skin biopsy. However, given that VCA comprised multiple tissue types, skin biopsy may not accurately reflect rejection in other transplanted tissue.

methodsA review of the literature on episodes of both acute and chronic rejection following VCA was completed. Special attention was given to how these patients were monitored for rejection and whether skin biopsy accurately reflected the state of other tissue types within VCA.

resultsFollowing VCA, skin biopsies accurately reflected episodes of acute rejection, but chronic rejection, resulting in both muscle fibrosis and graft vasculopathy, did not present with any ostensible skin changes.

conclusionVarious tissue types within VCA can reject at different times and rates. We define this phenomenon as "split rejection." Split rejection has significant implications on flap monitoring, as it suggests that skin biopsy alone may not be sufficient in monitoring long-term graft rejection.

Indexed as

acute rejectionchronic rejectionimmunosuppressionsplit rejectionvascularized composite allotransplantation

Identifiers

PMID24244785
PMCPMC3795428
OpenAlexW15559101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.